Philip L. Milstein - 31 Dec 2025 Form 4 Insider Report for MARCUS CORP (MCS)

Role
Director
Signature
/s/ Steven R. Barth, Attorney-in-Fact for Philip L. Milstein
Issuer symbol
MCS
Transactions as of
31 Dec 2025
Net transactions value
$0
Form type
4
Filing time
05 Jan 2026, 18:57:37 UTC
Previous filing
09 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MILSTEIN PHILIP L Director OGDEN CAP PROPERTIES, LLC, 545 MADISON AVENUE, 6TH FLOOR, NEW YORK /s/ Steven R. Barth, Attorney-in-Fact for Philip L. Milstein 05 Jan 2026 0001195907

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MCS Common Stock Award $0 +4,174 +5.7% $0.000000 77,758 31 Dec 2025 Direct F1
holding MCS Common Stock 10,244 31 Dec 2025 As trustee for PLM Foundation F2
holding MCS Common Stock 124,111 31 Dec 2025 As trustee for PLM Foundation F2
holding MCS Common Stock 8,100 31 Dec 2025 As trustee for PLM Foundation F2
holding MCS Common Stock 2,000 31 Dec 2025 As trustee for PLM Foundation F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MCS Stock Option (Right to Buy) 1,000 31 Dec 2025 Common Stock 1,000 $31.55 Direct
holding MCS Stock Option (Right to Buy) 1,000 31 Dec 2025 Common Stock 1,000 $27.20 Direct
holding MCS Stock Option (Right to Buy) 1,000 31 Dec 2025 Common Stock 1,000 $38.51 Direct
holding MCS Stock Option (Right to Buy) 1,000 31 Dec 2025 Common Stock 1,000 $32.60 Direct
holding MCS Stock Option (Right to Buy) 750 31 Dec 2025 Common Stock 750 $17.95 Direct
holding MCS Stock Option (Right to Buy) 1,438 31 Dec 2025 Common Stock 1,438 $14.25 Direct
holding MCS Stock Option (Right to Buy) 1,455 31 Dec 2025 Common Stock 1,455 $14.69 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock granted December 31, 2025 vests and becomes exercisable as follows: 50% after 2nd anniversary of date of grant and 100% after 4th anniversary of date of grant.
F2 The undersigned disclaims any beneficial interest in shares owned by his wife, children, held by him as trustee for PLM Foundation, or held by him as co-trustee for SVM Foundation.